DocGo Inc. Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss)
DocGo Inc. (DCGO) reported Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss) of $124.88 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Income Statement › Other Income
us-gaap:FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss · last filed 2026-03-16
- DocGo Inc. finite lived intangible assets, foreign currency translation gain (loss) for the quarter ending 2025-12-31 was $71.03K.
- DocGo Inc. finite lived intangible assets, foreign currency translation gain (loss) for the quarter ending 2025-09-30 was -$19.30K, a 162.74% decline year-over-year.
- DocGo Inc. finite lived intangible assets, foreign currency translation gain (loss) for the quarter ending 2025-06-30 was $49.36K, a 3679.33% increase year-over-year.
- DocGo Inc. finite lived intangible assets, foreign currency translation gain (loss) for the quarter ending 2025-03-31 was $23.79K.
- DocGo Inc. finite lived intangible assets, foreign currency translation gain (loss) for fiscal 2025 was $124.88K.
- DocGo Inc. finite lived intangible assets, foreign currency translation gain (loss) for fiscal 2024 was -$12.46K, a 244.47% decline from fiscal 2023.
- DocGo Inc. finite lived intangible assets, foreign currency translation gain (loss) for fiscal 2023 was $8.62K.
| Period end | Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss) 3 month | Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss) 6 month | Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss) 9 month | Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss) 12 month |
|---|---|---|---|---|
| 2025-12-31 | $71.03K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $51.73K derived: sum of 2 quarters · filed 2026-03-16 | $101.09K derived: sum of 3 quarters · filed 2026-03-16 | $124.88K 10-K · filed 2026-03-16 |
| 2025-09-30 | -$19.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $30.06K derived: sum of 2 quarters · filed 2025-11-10 | $53.85K 10-Q · filed 2025-11-10 | $12.38K derived: sum of 4 quarters · filed 2026-03-16 |
| 2025-06-30 | $49.36K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $73.15K 10-Q · filed 2025-08-07 | $31.68K derived: sum of 3 quarters · filed 2026-03-16 | $62.44K derived: sum of 4 quarters · filed 2026-03-16 |
| 2025-03-31 | $23.79K 10-Q · filed 2025-05-08 | -$17.68K derived: sum of 2 quarters · filed 2026-03-16 | $13.08K derived: sum of 3 quarters · filed 2026-03-16 | $14.39K derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-12-31 | -$41.47K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$10.71K derived: sum of 2 quarters · filed 2026-03-16 | -$9.40K derived: sum of 3 quarters · filed 2026-03-16 | -$12.46K 10-K · filed 2026-03-16 |
| 2024-09-30 | $30.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $32.07K derived: sum of 2 quarters · filed 2024-11-07 | $29.02K 10-Q · filed 2024-11-07 | $33.24K derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | $1.31K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$1.74K 10-Q · filed 2024-08-07 | $2.48K derived: sum of 3 quarters · filed 2024-08-07 | |
| 2024-03-31 | -$3.05K 10-Q · filed 2024-05-08 | $1.17K derived: sum of 2 quarters · filed 2024-05-08 | ||
| 2023-12-31 | $4.22K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $8.62K 10-K · filed 2024-02-28 | ||
| 2023-09-30 | $4.40K 10-Q · filed 2023-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |